AJCN Tufts Nutrition Symposium, Boston & Online Sept 2009
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Wang, K.-Y.
Right arrow Articles by Wang, W.-M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wang, K.-Y.
Right arrow Articles by Wang, W.-M.
Agricola
Right arrow Articles by Wang, K.-Y.
Right arrow Articles by Wang, W.-M.
American Journal of Clinical Nutrition, Vol. 80, No. 3, 737-741, September 2004
© 2004 American Society for Clinical Nutrition


ORIGINAL RESEARCH COMMUNICATION

Effects of ingesting Lactobacillus- and Bifidobacterium-containing yogurt in subjects with colonized Helicobacter pylori1,2,3

Kuan-Yuan Wang, Shui-Nin Li, Chiang-Shin Liu, Daw-Shyong Perng, Yu-Chung Su, Deng-Chyang Wu, Chang-Ming Jan, Chun-Huang Lai, Tsu-Nai Wang and Wen-Ming Wang

From the Department of Internal Medicine, Kaohsiung Municipal United Hospital, Kaohsiung, Taiwan, Republic of China (K-YW and C-HL); the Department of Biology (S-NL) and the School of Public Health (T-NW), Kaohsiung Medical University, Kaohsiung, Taiwan, Republic of China; and the Department of Pathology (C-SL) and the Department of Internal Medicine (D-SP, Y-CS, D-CW, C-MJ, and W-MW), Kaohsiung Medical University Hospital, Kaohsiung, Taiwan, Republic of China

Background: Evidence suggests that ingesting lactic acid bacteria exerts a suppressive effect on Helicobacter pylori infection in both animals and humans. Supplementing with Lactobacillus- and Bifidobacterium-containing yogurt (AB-yogurt) was shown to improve the rates of eradication of H. pylori in humans.

Objective: We administered AB-yogurt to subjects with asymptomatic H. pylori to test whether the yogurt could inhibit H. pylori growth.

Design: The in vitro inhibition of H. pylori growth was determined by inoculating Lactobacillus acidophilus La5 or Bifidobacterium lactis Bb12 on plates that were inoculated with H. pylori. Assessment of the viability of H. pylori was performed by the mixed culture method with La5 or Bb12. In an intervention study, 59 adult volunteers infected with H. pylori were given AB-yogurt (107 colony-forming units of both La5 and Bb12/mL) twice daily after a meal for 6 wk. Eleven subjects positive for H. pylori infection were treated with milk placebo as control subjects. H. pylori bacterial loads were determined with use of the 13C-urea breath test, which was performed before and 4 and 8 wk after the start of AB-yogurt supplementation.

Results: Bb12 exerted an in vitro inhibitory effect against H. pylori, whereas La5 did not show an effect. Administration of AB-yogurt decreased the urease activity of H. pylori after 6 wk of therapy (P < 0.0001).

Conclusion: Regular intake of yogurt containing Bb12 and La5 effectively suppressed H. pylori infection in humans.

Key Words: Probiotics • Bifidobacterium lactis Bb12 • Lactobacillus acidophilus La5 • urea breath test • yogurt • Helicobacter pylori




This article has been cited by other articles:


Home page
Nutr Clin PractHome page
J. M. Saavedra
Use of Probiotics in Pediatrics: Rationale, Mechanisms of Action, and Practical Aspects
Nutr Clin Pract, June 1, 2007; 22(3): 351 - 365.
[Abstract] [Full Text] [PDF]


Home page
J DAIRY SCIHome page
K. Miki, Y. Urita, F. Ishikawa, T. Iino, H. Shibahara-Sone, R. Akahoshi, S. Mizusawa, A. Nose, D. Nozaki, K. Hirano, et al.
Effect of Bifidobacterium bifidum Fermented Milk on Helicobacter pylori and Serum Pepsinogen Levels in Humans
J Dairy Sci, June 1, 2007; 90(6): 2630 - 2640.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
D. Lesbros-Pantoflickova, I. Corthesy-Theulaz, and A. L. Blum
Helicobacter pylori and Probiotics
J. Nutr., March 1, 2007; 137(3): 812S - 818S.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Clin. Nutr.Home page
B.-S. Sheu, H.-C. Cheng, A.-W. Kao, S.-T. Wang, Y.-J. Yang, H.-B. Yang, and J.-J. Wu
Pretreatment with Lactobacillus- and Bifidobacterium-containing yogurt can improve the efficacy of quadruple therapy in eradicating residual Helicobacter pylori infection after failed triple therapy.
Am. J. Clinical Nutrition, April 1, 2006; 83(4): 864 - 869.
[Abstract] [Full Text] [PDF]


Home page
Food Science and Technology InternationalHome page
M. C. Collado, Y. Moreno, E. Hernandez, J. M. Cobo, and M. Hernandez
Note. In Vitro Viability of Bifidobacterium Strains Isolated from Commercial Dairy Products Exposed to Human Gastrointestinal Conditions
Food Science and Technology International, August 1, 2005; 11(4): 307 - 314.
[Abstract] [PDF]


Home page
Am. J. Clin. Nutr.Home page
M. Gotteland, S. Cruchet, and O. Brunser
Can the amount of Helicobacter pylori in the stomach be kept low through probiotic intake?
Am. J. Clinical Nutrition, April 1, 2005; 81(4): 939 - 939.
[Full Text] [PDF]


Home page
Am. J. Clin. Nutr.Home page
Y.-C. Su, W.-M. Wang, and K.-Y. Wang
Reply to M Gotteland et al
Am. J. Clinical Nutrition, April 1, 2005; 81(4): 939 - 940.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2004 by The American Society for Nutrition